Chargement en cours...

Safety of lornoxicam in G-6-PDH deficiency

Objective: To assess the safety of lornoxicam in subjects with G-6-PDH deficiency. Methods: Open controlled 2-week in vivo study on lornoxicam 8 mg bid in subjects with G-6-PDH deficiency suffering from rheumatic diseases. Results: In 8 male patients with the Mediterranean form of G-6-PDH deficiency...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: G. Perpignano, E. Cacace, C. Matulli, V. Ruggiero
Format: Artigo
Langue:Inglês
Publié: PAGEPress Publications 2003-03-01
Collection:Reumatismo
Accès en ligne:https://reumatismo.org/index.php/reuma/article/view/103
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!